Quotient Sciences Quotient Sciences

X

CAS 10538-59-7 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 10538-59-7
Also known as: 10538-59-7, 7-ketolithocholic methyl ester, Nutriacholic acid methyl ester, Cholan-24-oic acid, 3-hydroxy-7-oxo-, methyl ester, (3a,5b)-, Methyl (4r)-4-[(3r,5s,8r,9s,10s,13r,14s,17r)-3-hydroxy-10,13-dimethyl-7-oxo-1,2,3,4,5,6,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoate, 3alpha-hydroxy-7-oxo-5beta-cholan-24-oic acid methyl ester
Molecular Formula
C25H40O4
Molecular Weight
404.6  g/mol
InChI Key
FNBYYFMYNRYPPC-YLOOLPOOSA-N

1 2D Structure

CAS 10538-59-7

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
methyl (4R)-4-[(3R,5S,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-7-oxo-1,2,3,4,5,6,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoate
2.1.2 InChI
InChI=1S/C25H40O4/c1-15(5-8-22(28)29-4)18-6-7-19-23-20(10-12-25(18,19)3)24(2)11-9-17(26)13-16(24)14-21(23)27/h15-20,23,26H,5-14H2,1-4H3/t15-,16+,17-,18-,19+,20+,23+,24+,25-/m1/s1
2.1.3 InChI Key
FNBYYFMYNRYPPC-YLOOLPOOSA-N
2.1.4 Canonical SMILES
CC(CCC(=O)OC)C1CCC2C1(CCC3C2C(=O)CC4C3(CCC(C4)O)C)C
2.1.5 Isomeric SMILES
C[C@H](CCC(=O)OC)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C(=O)C[C@H]4[C@@]3(CC[C@H](C4)O)C)C
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 10538-59-7

2. 7-ketolithocholic Methyl Ester

3. Nutriacholic Acid Methyl Ester

4. Cholan-24-oic Acid, 3-hydroxy-7-oxo-, Methyl Ester, (3a,5b)-

5. Methyl (4r)-4-[(3r,5s,8r,9s,10s,13r,14s,17r)-3-hydroxy-10,13-dimethyl-7-oxo-1,2,3,4,5,6,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoate

6. 3alpha-hydroxy-7-oxo-5beta-cholan-24-oic Acid Methyl Ester

7. Mfcd00271395

8. Methyl 7-ketolithocholate

9. Schembl2293490

10. 7-oxolithocholic Acid Methyl Ester

11. Dtxsid101258388

12. 24-o-methyl-7-oxolithocholic Acid

13. Zinc34035937

14. Akos026750739

15. Ac-29219

16. As-10724

17. Cs-0158187

18. Methyl 3alpha-hydroxy-7-keto-5beta-cholanate

19. Methyl 3alpha-hydroxy-7-keto-5beta-cholanoate

20. Methyl-3alpha-hydroxy-7-oxo-5beta-cholanoate

21. A857070

22. Methyl (3alpha,5beta)-3-hydroxy-7-oxocholan-24-oate

23. 3alpha-hydroxy-7-keto-5beta-cholan-24-oic Acid Methyl Ester

2.3 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 404.6 g/mol
Molecular Formula C25H40O4
XLogP35
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count5
Exact Mass404.29265975 g/mol
Monoisotopic Mass404.29265975 g/mol
Topological Polar Surface Area63.6 Ų
Heavy Atom Count29
Formal Charge0
Complexity659
Isotope Atom Count0
Defined Atom Stereocenter Count9
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
URL Supplier Web Content
10538-59-7
Jinan Xinke Pharmaceutical Science and Technology Co., Ltd. (XKPHARM) is an innovation driven company, he...
Jinan Xinke Pharmaceutical Science and Technology Co., Ltd. (XKPHARM) is an innovation driven company, headquartered in Jinan city, Shandong province, China and focus on the researching, manufacturing and marketing of high value added APIs and their intermediates. XKPHARM has set up a modern R&D center in High-Tech Industrial Development Zone of Jinan city, which covers over 1000 square meters and owns a professional team. Our R&D center specialized in research and development of cutting-edge information and technology, thus providing a platform for the company's sustainably developing market competition.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
10538-59-7
7-ketolithocholic Methyl ester
Waterstone is an international pharmaceutical company with its main operations in China. The company is ...
Waterstone is an international pharmaceutical company with its main operations in China. The company is focused in discovery, development and commercialization of innovative drugs for the treatment of liver and gastrointestinal diseases. With venture capital investments from internationally well-known firms such as BAR Capital, CID Group, Orbimed, and Acorn Camps, the company has established fully integrated capabilities from R&D, API & Finished Drug Product manufacturing to sales/marketing. The company has a strong management team with cross-border experience and advisors with expertise in drug discovery, regulatory, and GMP manufacturing. On top of the forty marked drugs in China, the company has also built a rich pipeline including Drug Master Files with U.S. FDA , candidates in phase II/III clinical tries with cFDA, and several novel preclinical stage antiviral and oncology candidates
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY